Amber Specialty Pharmacy Begins Dispensing Newly Approved BRINSUPRI™ (brensocatib) for Non-Cystic Fibrosisbronchiectasis (NCFB)
'Our nationally recognized clinical program is ready to ensure rapid access, personalized counseling, and comprehensive reimbursement support for every patient who needs it,' said Kristin Williams, president of Amber Specialty Pharmacy.
Amber Specialty Pharmacy streamlines the treatment process for both patients and referring providers by offering the following support services:
Nationwide dispensing through its URAC and ACHC-accredited network
24/7 clinical support and adherence counseling from specialty-licensed pharmacists
End-to-end benefits investigation, prior authorization and financial assistance coordination
Healthcare providers can initiate BRINSUPRI referrals by calling (888) 370-1724 or visiting amberpharmacy.com/providers/referral-forms to download electronic referral forms.
About Amber Specialty Pharmacy
Amber Specialty Pharmacy is a pioneer in the specialty pharmacy industry, with more than 25 years of experience in providing specialized care for patients with chronic and complex medical conditions. With a focus on personalized support and quality clinical care, Amber Specialty Pharmacy serves patients across the United States. The pharmacy is accredited by both the Utilization Review Accreditation Commission (URAC) and the Accreditation Commission for Health Care (ACHC). Amber Specialty Pharmacy is headquartered in Omaha, Nebraska. To learn more, visit www.amberpharmacy.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
10 minutes ago
- Business Wire
CILA Therapeutics Awarded NCATS Grant to Advance a Transformational Platform That Significantly Enhances Inhaled Delivery of RNA-LNP Into Lung Cells
BOSTON--(BUSINESS WIRE)-- CILA Therapeutics has been awarded a competitive grant from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to advance the development of its proprietary CIL-Key™ platform — a novel, gene-agnostic delivery technology that significantly and reproducibly enhances the transfection efficiency and delivery of inhaled RNA-loaded lipid nanoparticles (RNA-LNPs) into lung epithelial cells. 'This milestone provides strong validation of CILA's scientific approach and vision to deliver practical, scalable and patient-centric solutions for some of the most formidable challenges in pulmonary medicine," said Safia Rizvi, CEO, CILA Therapeutics Share In preclinical studies, the CIL-Key™ platform (also referred to as CIL-0X in the grant) achieved up to a 430% increase in delivery of functionally intact RNA into human bronchial epithelial cells cultured at an air-liquid interface (ALI), demonstrating utility across multiple RNA-LNP formulations. 'This milestone provides strong validation of CILA's scientific approach and vision to deliver practical, scalable and patient-centric solutions for some of the most formidable challenges in pulmonary medicine,' said Safia Rizvi, CEO of CILA Therapeutics. CIL-Key™ is designed to enable efficient, localized intracellular delivery of RNA-based modalities while minimizing systemic exposure. The platform could offer significant advantages for companies developing inhaled RNA therapies and vaccines for a broad range of lung diseases, including Primary Ciliary Dyskinesia (PCD), Cystic Fibrosis (CF), COPD and Pulmonary Fibrosis, as well as respiratory infections including influenza, RSV and COVID-19. Chronic pulmonary diseases affect more than 34 million people in the U.S. and more than 545 million globally. These often progressive, life-limiting conditions have a significant impact on quality of life and a high economic burden, creating an urgent demand for novel, effective and easy-to-administer treatments like those powered by CIL-Key™. About CILA Therapeutics CILA Therapeutics is a biotechnology company focused on improving lung health through transformative, scalable, accessible therapies and technologies that easily integrate into patients' daily lives. Its vision is to empower people with pulmonary diseases to breathe easily and live fully. CILA's pipeline includes first-in-class inhaled therapeutics and CIL-Key™, a proprietary platform to enhance delivery of RNA-based therapeutics and vaccines targeting a wide spectrum of pulmonary diseases. Visit CILA is actively seeking strategic partnerships to expand the platform's application across diverse RNA-based pipelines for rare and common pulmonary indications.
Yahoo
19 minutes ago
- Yahoo
RAM Technologies' Rapid Growth Earns National Recognition on Inc. 5000 List
PHILADELPHIA, August 14, 2025--(BUSINESS WIRE)--RAM Technologies, Inc., a leading technology enabled services provider to Medicare Advantage, Special Needs and Managed Medicaid health plans, has earned a place on the 2025 Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. With three-year revenue growth of nearly 100%, this marks the company's ninth time on the list. The Inc. 5000 offers a data-driven look at the nation's most successful companies within the economy's most dynamic segment—independent, entrepreneurial businesses. Rankings are based on percentage revenue growth from 2021 to 2024, and RAM Technologies was honored for its exceptional growth and innovation. "It's an honor to once again be recognized on the Inc. 5000 list," said Robert Tulio, CEO of RAM Technologies. "Our growth is the result of a clear mission to equip government-sponsored health plans with software and services to operate efficiently and put members at the center of every decision. This achievement reflects the impact we're making in the healthcare industry, and our team's focus on innovation and quality." The company's sustained growth has been fueled by expanding relationships with health plans nationwide, a commitment to exceptional client service and the ability to provide BPaaS solutions that enhance outcomes for clients. RAM Technologies specializes in delivering purpose-built solutions for government-sponsored health plans. The company's core platform, HEALTHsuite Advantage, gives health plans added flexibility through the choice of SaaS and BPaaS deployment models. By combining software with expert implementation and support, RAM helps health plans reduce costs, streamline operations and improve member experiences. "Our solutions give health plans tools to operate more efficiently, deliver a better experience for members and ensure compliance with regulatory requirements," said Tulio. "We're proud to have achieved sustained growth in such a competitive market, and we remain focused on delivering solutions to help our clients succeed." For the full list, company profiles, and a searchable database by industry and location, visit: About RAM Technologies RAM Technologies is a leading provider of enterprise solutions for government-sponsored healthcare payers. For over 44 years RAM Technologies has led the way in the creation of comprehensive, end-to-end SaaS and BPaaS solutions for health plans administering Medicare Advantage, Managed Medicaid and Special Needs plans. Our deep understanding of Medicare and Medicaid guarantees seamless integration and operational ease, allowing health plan staff to focus on what matters most. To learn more about RAM Technologies visit View source version on Contacts Media Contact Robert Meyer, RAM Technologies, Inc., rmeyer@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
40 minutes ago
- Business Wire
Nurse-to-Patient Ratios Save Lives and Reduce Staff Burnout, Says New Academic Study
OTTAWA, Ontario--(BUSINESS WIRE)--A new academic study says mandating nurse-to-patient ratios would save lives, improve overall outcomes for patients, and alleviate the staffing crisis in Ontario's hospitals. Based on an extensive review of existing research on staffing levels in hospitals, in-depth interviews with many Ontario hospital nurses, and an examination of mandated nursing staffing standards in places like California, British Columbia, Nova Scotia and Australia, the researchers recommend Ontario's hospitals adopt a similar policy to ensure safe staffing levels at all times. 'The evidence shows that nurse-patient ratios save lives,' said Dr. Jim Brophy, co-author of the study and a researcher affiliated with the University of Windsor. 'Assigning nurses a manageable workload ensures patients receive appropriate care, which in a high-stakes hospital environment can mean the difference between life and death.' Dr. Brophy said the evidence was overwhelming on the issue, with one study showing a seven per cent rise in death rates for every additional patient assigned to a nurse. He said another study from the U.K. showed that hospitals with the worst nurse staffing levels had 26 per cent higher death rates. Conversely, death rates declined in California's hospitals after nursing ratios came into effect in 2004. Nurse-patient ratios are generally associated with a positive impact on patient care, he said, being associated with 'lower levels of medical errors, decreased risk of infections, and lower readmission rates.' Dr. Margaret Keith, co-author of the study, said mandating nurse-patient ratios would address Ontario's nursing shortage. Between 2022 and 2024, nurse vacancy rates in the province shot up by 43 per cent. 'Ratios equate to safe staffing levels for nurses,' she said. 'Mandated ratios reduce injury rates and burnout, reduce the moral distress of not being able to provide optimum care, and thereby improve staff satisfaction and morale. Addressing these factors would tremendously improve the retention and recruitment problem in Ontario's hospitals.' Based on August 2025 data from The College of Nurses of Ontario, there are 16,437 licensed but non-practicing nurses in the province. Keith said Ontario would do well to emulate the Australian province of Victoria, where mandated staffing ratios resulted in a 24 per cent increase in the nursing workforce with more than 7,000 inactive nurses resuming practice. 'It's an incredible story that shows it is possible to fix the health care staffing crisis,' she said. 'We know that attrition rates are very high in Ontario, and this solution could help stem the bleeding.' Recently, other provincial governments in Canada have taken initiative on minimum nurse staffing levels with employers in British Columbia and Nova Scotia obligated to adhere to newly enforced standards. In Manitoba, the government, employers, and the unions have signed a letter of intent to study the matter. Rachel Fleming, a registered practical nurse and member of the Canadian Union of Public Employees' (CUPE) Ontario Council of Hospital Unions (OCHU-CUPE), says inadequate staffing ratios are taking a devastating toll — not only on patient care but also on the emotional well-being of nurses. 'Every day, we're being forced to make choices that go against everything we believe as caregivers,' said Fleming. 'When you can't give medication on time, when a patient goes without a bath or the comfort of someone simply listening to them, when you can't even answer a call bell because you're torn between other patients in desperate need—it breaks your spirit. I know so many incredible nurses who walked away not because they stopped caring, but because the pain of not being able to care properly became unbearable.' According to the authors of the report, nursing ratios also have the potential to save costs by decreasing reliance on private agency staff, reducing avoidable readmissions, as well as workplace injuries and illnesses. In California, workplace injuries reduced by 32 per cent after the introduction of nursing ratios while hospitals in Pennsylvania with lower staff burnout rates had 6,200 fewer infections for annual cost-savings of up to $68 million. OCHU-CUPE will be proposing nurse-patient ratios for 50,000 hospital workers in central bargaining with the Ontario Hospital Association next month. However, the union is wary of the hospitals' opposition to the idea. 'Hospital management in the past rejected nurse-patient ratios, despite evidence that these ratios save lives and improve health outcomes for patients, because they restrict their ability to understaff – a reality forced on them by Ontario's chronic underfunding of our hospitals,' said Michael Hurley, president of OCHU-CUPE. 'Ratios will bring thousands of nurses who have left the profession in despair back to work. Adopting ratios in bargaining will push the provincial government to fund and staff its hospitals properly. For patients and for nurses, it is time for this fundamental change.' Last year, the Ontario PC MPPs voted against an NDP bill to legislate nurse-to-patient ratios in hospitals. The bill was reintroduced by the NDP in May 2025 but has yet to be debated. :gv/cope491
